New Zealand markets closed

Bellevue Life Sciences Acquisition Corp. (BLAC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.72-0.19 (-1.74%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 60.28M
Enterprise value 60.42M
Trailing P/E 214.40
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.85
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 35.30%
S&P500 52-week change 327.04%
52-week high 311.60
52-week low 310.17
50-day moving average 310.69
200-day moving average 310.52

Share statistics

Avg vol (3-month) 330.6k
Avg vol (10-day) 313.16k
Shares outstanding 55.62M
Implied shares outstanding 65.62M
Float 83.12M
% held by insiders 137.36%
% held by institutions 157.26%
Shares short (30 Apr 2024) 41.31k
Short ratio (30 Apr 2024) 40.03
Short % of float (30 Apr 2024) 40.03%
Short % of shares outstanding (30 Apr 2024) 40.02%
Shares short (prior month 28 Mar 2024) 41.51k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-6.05%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)403.78k
Diluted EPS (ttm)0.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.42k
Total cash per share (mrq)0
Total debt (mrq)72k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.01
Book value per share (mrq)-0.69

Cash flow statement

Operating cash flow (ttm)-818.77k
Levered free cash flow (ttm)768.51k